Singapore markets closed
Straits Times Index
3,280.10 -7.65 (-0.23%) Nikkei
37,934.76 +306.28 (+0.81%) Hang Seng
17,651.15 +366.61 (+2.12%) FTSE 100
8,139.83 +60.97 (+0.75%) Bitcoin USD
63,968.57 -606.48 (-0.94%) CMC Crypto 200
1,330.35 -66.19 (-4.74%)
Incyte Corporation (INCY)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
As of 01:51PM EDT. Market open.
| Previous close | 51.18 |
| Open | 50.90 |
| Bid | 51.51 x 400 |
| Ask | 51.61 x 100 |
| Day's range | 50.87 - 51.85 |
| 52-week range | 50.27 - 75.74 |
| Volume | |
| Avg. volume | 1,768,538 |
| Market cap | 11.57B |
| Beta (5Y monthly) | 0.67 |
| PE ratio (TTM) | 19.45 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Business Wire
Incyte Announces Acquisition of Escient Pharmaceuticals and its Pipeline of First-in-Class Oral MRGPR Antagonists
WILMINGTON, Del. & SAN DIEGO, April 23, 2024--Incyte Announces Acquisition of Escient Pharmaceuticals and its Pipeline of First-in-Class Oral MRGPR Antagonists
- Business Wire
Incyte to Report First Quarter Financial Results
WILMINGTON, Del., April 11, 2024--Incyte (Nasdaq:INCY) announced today that it has scheduled its first quarter financial results conference call and webcast for 8:00 a.m. ET on Tuesday, April 30, 2024.
- Business Wire
Incyte and CMS Announce Collaboration and License Agreement for Povorcitinib, an Oral JAK1 Inhibitor, in Mainland China, Hong Kong, Macau, Taiwan and Southeast Asia
WILMINGTON, Del. and HONG KONG, April 01, 2024--Incyte and CMS Announce Collaboration and License Agreement for Povorcitinib in Mainland China, Hong Kong, Macau, Taiwan and Southeast Asia
© 2024 Yahoo. All rights reserved.